Selected article for: "acute respiratory syndrome and antiviral drug development"
Author: Shou, Shuyu; Liu, Menghui; Yang, Yang; Kang, Ning; Song, Yingying; Tan, Dan; Liu, Nannan; Wang, Feifei; Liu, Jing; Xie, Youhua
Title: Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates
  • Cord-id: fg933r9j
  • Document date: 2021_8_31
    • ID: fg933r9j
    Snippet: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus causing acute respiratory tract infection in humans. The virus has the characteristics of rapid transmission, long incubation period and strong pathogenicity, and has spread all over the world. Therefore, it is of great significance to select appropriate animal models for antiviral drug development and therapeutic effect evaluation. Here, we review and compare the current animal models of SARS-CoV-2.
    Document: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus causing acute respiratory tract infection in humans. The virus has the characteristics of rapid transmission, long incubation period and strong pathogenicity, and has spread all over the world. Therefore, it is of great significance to select appropriate animal models for antiviral drug development and therapeutic effect evaluation. Here, we review and compare the current animal models of SARS-CoV-2.

    Search related documents:
    Co phrase search for related documents
    • activity decrease and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • activity decrease and adaptive immunity: 1
    • acute ards respiratory distress syndrome and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and adaptive sars immune response: 1
    • acute bronchiolitis and adaptive immunity: 1
    • acute lung injury and adaptive immunity: 1, 2, 3, 4, 5, 6
    • acute lung injury and adaptive sars immune response: 1
    • acute lung pathology and adaptive immunity: 1
    • acute respiratory syndrome coronavirus and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome coronavirus and adaptive mutation: 1, 2, 3, 4, 5
    • acute respiratory syndrome coronavirus and adaptive sars immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acute tubular necrosis and adaptive immunity: 1